This session will explore how pharmacy teams can lead proactive care for frailty by shifting from falls treatment to falls prevention, through targeted deprescribing of Falls Risk Increasing Drugs (FRIDs)

It will cover the clinical rationale (NICE Guidance 249), the use of the WHO Predictive, Preventative, Personalised, Participatory approach, including identifying high-risk populations and patients, practical medication review and deprescribing strategies, and why embedding these within routine integrated multidisciplinary team (MDT) care pathways is essential

Aligned with the NHS Long Term Plan, the session will highlight the role of pharmacy within Integrated Neighbourhood Teams to deliver joined-up, prevention-focused care to improve safety, mobility and independence for older people, reduce medicines related harm, avoidable hospital admissions and unnecessary health and social care demand

Through real world examples attendees will gain practical tools to implement deprescribing, insights into overcome common barriers, and strategies to influence and drive system-wide change to keep older people safe, steady and mobile while reducing system pressures

• 1. Learn that medicines is one of several falls risk factors that lead to poor health, reduced independence, health inequalities, hospitalisation, increased resource utilisation, health and care costs, and why deprescribing FRIDs is critical in multifactorial falls prevention.
• 2. Gain skills to identify FRIDs, high-risk patients and populations, implement and embed structured medication reviews (with deprescribing) within strategies to reduce falls
• 3. Explain how pharmacy can contribute to NHS Long Term Plan and ICS priorities to shift from reactive to proactive care within Integrated Neighbourhood Teams, through pharmacy led medicines optimisation interventions to reduce falls risks
• 4. Gain insight into how deprescribing FRIDs improve outcomes and impact; by older people to stay steady, safe and mobile, as well as contribute to ICS objectives to reduce avoidable hospital admissions, address health inequalities, and maximise medicines value